• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

老年作为肝脏疾病的一个风险因素:现代治疗方法

Old age as a risk factor for liver diseases: Modern therapeutic approaches.

作者信息

Georgieva Milena, Xenodochidis Charilaos, Krasteva Natalia

机构信息

Institute of Molecular Biology "Acad. Roumen Tsanev", Bulgarian Academy of Sciences, 1113 Sofia, Bulgaria.

Institute of Biophysics and Biomedical Engineering, Bulgarian Academy of Sciences, 1113 Sofia, Bulgaria.

出版信息

Exp Gerontol. 2023 Dec;184:112334. doi: 10.1016/j.exger.2023.112334. Epub 2023 Nov 25.

DOI:10.1016/j.exger.2023.112334
PMID:37977514
Abstract

Recent scientific interest has been directed towards age-related diseases, driven by the significant increase in global life expectancy and the growing population of individuals aged 65 and above. The ageing process encompasses various biological, physiological, environmental, psychological, behavioural, and social changes, leading to an augmented susceptibility to chronic illnesses. Cardiovascular, neurological, musculoskeletal, liver and oncological diseases are prevalent in the elderly. Moreover, ageing individuals demonstrate reduced regenerative capacity and decreased tolerance towards therapeutic interventions, including organ transplantation. Liver diseases, such as non-alcoholic fatty liver disease, alcoholic liver disease, hepatitis, fibrosis, and cirrhosis, have emerged as significant public health concerns. Paradoxically, these conditions remain underestimated despite their substantial global impact. Age-related factors are closely associated with the severity and unfavorable prognosis of various liver diseases, warranting further investigation to enhance clinical management and develop novel therapeutic strategies. This comprehensive review focuses specifically on age-related liver diseases, their treatment strategies, and contemporary practices. It provides a detailed account of the global burden, types, molecular mechanisms, and epigenetic alterations underlying these liver pathologies.

摘要

近期,受全球预期寿命显著增加以及65岁及以上人口不断增长的推动,科学界的兴趣已转向与年龄相关的疾病。衰老过程涵盖各种生物、生理、环境、心理、行为和社会变化,导致对慢性病的易感性增加。心血管疾病、神经疾病、肌肉骨骼疾病、肝脏疾病和肿瘤疾病在老年人中很常见。此外,老年人的再生能力下降,对包括器官移植在内的治疗干预的耐受性降低。肝脏疾病,如非酒精性脂肪性肝病、酒精性肝病、肝炎、纤维化和肝硬化,已成为重大的公共卫生问题。矛盾的是,尽管这些疾病对全球有重大影响,但仍未得到充分重视。与年龄相关的因素与各种肝脏疾病的严重程度和不良预后密切相关,需要进一步研究以加强临床管理并制定新的治疗策略。这篇综述特别关注与年龄相关的肝脏疾病、其治疗策略和当代实践。它详细阐述了这些肝脏疾病的全球负担、类型、分子机制和表观遗传改变。

相似文献

1
Old age as a risk factor for liver diseases: Modern therapeutic approaches.老年作为肝脏疾病的一个风险因素:现代治疗方法
Exp Gerontol. 2023 Dec;184:112334. doi: 10.1016/j.exger.2023.112334. Epub 2023 Nov 25.
2
Practical approach to non-alcoholic fatty liver disease in patients with diabetes.糖尿病患者非酒精性脂肪性肝病的实用治疗方法
Diabet Med. 2015 Sep;32(9):1121-33. doi: 10.1111/dme.12725. Epub 2015 Mar 18.
3
Causes of Mortality in Non-Alcoholic Fatty Liver Disease (NAFLD) and Alcohol Related Fatty Liver Disease (AFLD).非酒精性脂肪性肝病(NAFLD)和酒精性相关脂肪性肝病(AFLD)患者的死亡原因。
Curr Pharm Des. 2020;26(10):1079-1092. doi: 10.2174/1381612826666200128094231.
4
Challenges and Management of Liver Cirrhosis: Practical Issues in the Therapy of Patients with Cirrhosis due to NAFLD and NASH.肝硬化的挑战与管理:非酒精性脂肪性肝病和非酒精性脂肪性肝炎所致肝硬化患者治疗中的实际问题
Dig Dis. 2015;33(4):598-607. doi: 10.1159/000375353. Epub 2015 Jul 6.
5
Hepatic Outcomes of Nonalcoholic Fatty Liver Disease Including Cirrhosis and Hepatocellular Carcinoma.非酒精性脂肪性肝病包括肝硬化和肝细胞癌的肝脏结局。
Clin Liver Dis. 2023 May;27(2):211-223. doi: 10.1016/j.cld.2023.01.019. Epub 2023 Mar 9.
6
Modern approach to the clinical management of non-alcoholic fatty liver disease.非酒精性脂肪性肝病临床管理的现代方法。
World J Gastroenterol. 2014 Jul 14;20(26):8341-50. doi: 10.3748/wjg.v20.i26.8341.
7
[Emphasis on clinical study of heterogeneity of non-alcoholic fatty liver disease].[重视非酒精性脂肪性肝病的异质性临床研究]
Zhonghua Gan Zang Bing Za Zhi. 2020 Mar 20;28(3):193-197. doi: 10.3760/cma.j.cn501113-20200317-00119.
8
Changes in the Global Burden of Chronic Liver Diseases From 2012 to 2017: The Growing Impact of NAFLD.2012 年至 2017 年全球慢性肝病负担的变化:非酒精性脂肪性肝病的影响日益增加。
Hepatology. 2020 Nov;72(5):1605-1616. doi: 10.1002/hep.31173. Epub 2020 Oct 27.
9
Treatment options for alcoholic and non-alcoholic fatty liver disease: A review.酒精性和非酒精性脂肪性肝病的治疗选择:综述。
World J Gastroenterol. 2017 Sep 28;23(36):6549-6570. doi: 10.3748/wjg.v23.i36.6549.
10
Association between Cardiovascular Disease and Liver Disease, from a Clinically Pragmatic Perspective as a Cardiologist.从心内科医生的临床实用角度看心血管疾病与肝脏疾病的关联。
Nutrients. 2023 Feb 1;15(3):748. doi: 10.3390/nu15030748.

引用本文的文献

1
The impact of diabetes and social, biologic and behavioral determinants of health on liver cancer risk.糖尿病以及健康的社会、生物学和行为决定因素对肝癌风险的影响。
Front Endocrinol (Lausanne). 2025 Jun 27;16:1562854. doi: 10.3389/fendo.2025.1562854. eCollection 2025.
2
The global impact of non-alcoholic fatty liver disease (including cirrhosis) in the elderly from 1990 to 2021 and future projections of disease burden.1990年至2021年非酒精性脂肪性肝病(包括肝硬化)对老年人的全球影响及疾病负担的未来预测。
PLoS One. 2025 Jun 25;20(6):e0325961. doi: 10.1371/journal.pone.0325961. eCollection 2025.
3
Cell cycle regulation by the ribotoxic stress response.
核糖体毒性应激反应对细胞周期的调控。
Trends Cell Biol. 2025 Jul;35(7):592-603. doi: 10.1016/j.tcb.2025.04.005. Epub 2025 May 16.
4
Calorie-restriction treatment mitigates the aging in rat liver model.热量限制疗法可减轻大鼠肝脏模型中的衰老。
Biogerontology. 2025 May 7;26(3):108. doi: 10.1007/s10522-025-10245-8.
5
Canine-derived ZJUIDS-D034 and ZJUIDS-D016 combat aging by regulating gut microbiota.犬源ZJUIDS-D034和ZJUIDS-D016通过调节肠道微生物群来对抗衰老。
Curr Res Microb Sci. 2025 Mar 30;8:100381. doi: 10.1016/j.crmicr.2025.100381. eCollection 2025.
6
Evaluating the regional and demographic variables in alcoholic liver disease-related mortality trends in the United States from 1999 to 2020: A cross sectional study.评估1999年至2020年美国酒精性肝病相关死亡率趋势中的区域和人口统计学变量:一项横断面研究。
Medicine (Baltimore). 2025 Apr 4;104(14):e41988. doi: 10.1097/MD.0000000000041988.
7
Identifying liver cirrhosis in patients with chronic hepatitis B: an interpretable machine learning algorithm based on LSM.识别慢性乙型肝炎患者中的肝硬化:一种基于肝脏硬度值(LSM)的可解释机器学习算法。
Ann Med. 2025 Dec;57(1):2477294. doi: 10.1080/07853890.2025.2477294. Epub 2025 Mar 19.
8
Real-World Trends and Future Projections of the Prevalence of Cirrhosis and Hepatic Encephalopathy Among Commercially and Medicare-Insured Adults in the United States.美国商业保险和医疗保险覆盖的成年人中肝硬化和肝性脑病患病率的真实世界趋势及未来预测
Clin Transl Gastroenterol. 2025 Jan 21;16(5). doi: 10.14309/ctg.0000000000000823.
9
Exceeding the Limits with Nutraceuticals: Looking Towards Parkinson's Disease and Frailty.营养保健品突破极限:展望帕金森病与身体虚弱问题
Int J Mol Sci. 2024 Dec 26;26(1):122. doi: 10.3390/ijms26010122.
10
Cirrhosis associated with increased complications and healthcare utilization following total shoulder arthroplasty.全肩关节置换术后肝硬化与并发症增加及医疗资源利用增多相关。
Shoulder Elbow. 2024 Dec 18:17585732241306098. doi: 10.1177/17585732241306098.